
Looking to sell Iterative Health stock or options?
Iterative Health develops a clinical research site network designed to accelerate gastroenterology studies. The company provides a platform enhanced by artificial intelligence, extensive site access, and effective patient recruitment, allowing pharmaceutical and biotechnology firms to conduct trials more rapidly than traditional methods.


Seae Ventures, Micron Ventures, Lilly USA, Tau Ventures, MIT Innovation Initiative, MedTech Innovator, Wavemaker Partners, Obvious Ventures, Time BioVentures, Frederic Kerrest.